NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • NIHR Oxford BRC impact
    • Steering Committee
    • Promoting equality, diversity and inclusion in research
    • Current Vacancies
    • Stay in Touch
    • Contact Us
  • Research

        • Research Overview
        • Clinical Research Facility
        • Health Economics
        • Ethics in the NIHR Oxford BRC
        • Medical Statistics
        • Infections in Oxfordshire Database (IORD)
        • 15 Research Themes

        • Cancer
        • Cardiovascular Medicine
        • Digital Health from Hospital to Home
        • Gene and Cell Therapy
        • Genomic Medicine
        • Imaging
        • Inflammation across Tissues
        • Life-saving Vaccines
        • Metabolic Experimental Medicine
        • Modernising Medical Microbiology and Big Infection Diagnostics
        • Musculoskeletal
        • Preventive Neurology
        • Respiratory Medicine
        • Surgical Innovation, Technology and Evaluation
        • Translational Data Science
  • Patient and Public Involvement
    • For patients and the public
    • For researchers
    • More information
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Pre-doctoral Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • PARC Programme
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events

** HEALTH RESEARCH SHOWCASE THURSDAY 29 MAY 2025 **

News

You are here: Home > Respiratory Medicine > Serious asthma attacks reduced by temporary quadrupling of steroid inhaler, study finds

Serious asthma attacks reduced by temporary quadrupling of steroid inhaler, study finds

9 March 2018 · Listed under Respiratory Medicine

Serious asthma attacks in adults can be reduced by a temporary but significant increase in the dose of inhaled steroids during asthma deteriorations, according to a new national study involving NIHR Oxford BRC.

The Fourfold Asthma Study (FAST), published in the New England Journal of Medicine this week was led by asthma experts at the University of Nottingham and co-authored by the NIHR Oxford BRC Respiratory Theme Lead, Prof Ian Pavord.

Previous research in Nottingham found that doubling the dose of inhaled steroids during worsening asthma did not prevent the frequency of serious attacks. This new NIHR-funded clinical trial was set up to see if quadrupling the dose had a more beneficial effect.

The study compared two asthma self-management plans in a large trial involving nearly 2000 patient volunteers in England and Scotland. Around half the patients were randomly assigned to the plan that prescribed a quadrupling of inhaled steroid during periods of worsening asthma and the other half followed the current standard self-care plan over a period of 12 months.

The study showed that the participants in the quadrupling group had a 20 per cent reduction in severe asthma attacks compared with the usual care group and they also had fewer asthma-related hospital admissions, with only three patients in the quadrupling group admitted to hospital, compared to 18 in the usual care group.

This self-management approach could result in reduced need for oral steroids such as prednisolone, fewer admissions to hospital with severe asthma and hopefully fewer deaths from asthma.

Read more about the study.

← Respiratory theme showcased at Brookes Science Bazaar
Oxford researcher gets £1m boost to study immunology of asthma →

Other news

News Categories

News by Month

See all news

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Feedback

We’d love to hear your feedback. Please contact us at [email protected]

Oxford BRC on Social Media

  • Bluesky
  • Facebook
  • LinkedIn
  • Threads
  • Twitter
  • YouTube
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2025 NIHR Oxford Biomedical Research Centre